Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

Discrete roles and bifurcation of PTEN signaling and mTORC1-mediated anabolic metabolism underlie IL-7-driven B lymphopoiesis.

Zeng H, Yu M, Tan H, Li Y, Su W, Shi H, Dhungana Y, Guy C, Neale G, Cloer C, Peng J, Wang D, Chi H.

Sci Adv. 2018 Jan 31;4(1):eaar5701. doi: 10.1126/sciadv.aar5701. eCollection 2018 Jan.

2.

mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation.

Zeng H, Cohen S, Guy C, Shrestha S, Neale G, Brown SA, Cloer C, Kishton RJ, Gao X, Youngblood B, Do M, Li MO, Locasale JW, Rathmell JC, Chi H.

Immunity. 2016 Sep 20;45(3):540-554. doi: 10.1016/j.immuni.2016.08.017. Epub 2016 Sep 13.

3.

Exon skipping restores dystrophin expression, but fails to prevent disease progression in later stage dystrophic dko mice.

Wu B, Cloer C, Lu P, Milazi S, Shaban M, Shah SN, Marston-Poe L, Moulton HM, Lu QL.

Gene Ther. 2014 Sep;21(9):785-93. doi: 10.1038/gt.2014.53. Epub 2014 Jun 19.

4.

Evaluation of Tris[2-(acryloyloxy)ethyl]isocyanurate cross-linked polyethylenimine as antisense morpholino oligomer delivery vehicle in cell culture and dystrophic mdx mice.

Wang M, Wu B, Tucker JD, Lu P, Cloer C, Lu QL.

Hum Gene Ther. 2014 May;25(5):419-27. doi: 10.1089/hum.2013.156. Epub 2014 Apr 25.

5.

mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function.

Zeng H, Yang K, Cloer C, Neale G, Vogel P, Chi H.

Nature. 2013 Jul 25;499(7459):485-90. doi: 10.1038/nature12297. Epub 2013 Jun 30.

6.

Polyethylenimine-modified pluronics (PCMs) improve morpholino oligomer delivery in cell culture and dystrophic mdx mice.

Wang M, Wu B, Lu P, Cloer C, Tucker JD, Lu Q.

Mol Ther. 2013 Jan;21(1):210-6. doi: 10.1038/mt.2012.236. Epub 2012 Nov 20.

7.

Long-term rescue of dystrophin expression and improvement in muscle pathology and function in dystrophic mdx mice by peptide-conjugated morpholino.

Wu B, Lu P, Cloer C, Shaban M, Grewal S, Milazi S, Shah SN, Moulton HM, Lu QL.

Am J Pathol. 2012 Aug;181(2):392-400. doi: 10.1016/j.ajpath.2012.04.006. Epub 2012 Jun 7.

8.

Tris[2-(acryloyloxy)ethyl]isocyanurate cross-linked low-molecular-weight polyethylenimine as gene delivery carriers in cell culture and dystrophic mdx mice.

Wang M, Tucker JD, Lu P, Wu B, Cloer C, Lu Q.

Bioconjug Chem. 2012 Apr 18;23(4):837-45. doi: 10.1021/bc200674e. Epub 2012 Apr 4.

PMID:
22443086
9.

Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug development.

Wu B, Benrashid E, Lu P, Cloer C, Zillmer A, Shaban M, Lu QL.

PLoS One. 2011;6(5):e19906. doi: 10.1371/journal.pone.0019906. Epub 2011 May 17.

10.

One-year treatment of morpholino antisense oligomer improves skeletal and cardiac muscle functions in dystrophic mdx mice.

Wu B, Xiao B, Cloer C, Shaban M, Sali A, Lu P, Li J, Nagaraju K, Xiao X, Lu QL.

Mol Ther. 2011 Mar;19(3):576-83. doi: 10.1038/mt.2010.288. Epub 2010 Dec 21.

11.

Erythropoietin (EPO) influences colonic anastomotic healing in a rat model by modulating collagen metabolism.

Kaemmer DA, Otto J, Binneboesel M, Klink C, Krones C, Jansen M, Cloer C, Oettinger A, Schumpelick V, Klinge U.

J Surg Res. 2010 Oct;163(2):e67-72. doi: 10.1016/j.jss.2010.04.053. Epub 2010 May 22.

PMID:
20739030
12.

Compressed collagen sponges as gastroretentive dosage forms: in vitro and in vivo studies.

Gröning R, Cloer C, Georgarakis M, Müller RS.

Eur J Pharm Sci. 2007 Jan;30(1):1-6. Epub 2006 Aug 12.

PMID:
17101267
13.

Supplemental Content

Support Center